Mesenchymal stromal cell plasticity and the tumor microenvironment

Area of Science:

• Immunology
• Cell Biology
• Oncology

Background:

• Mesenchymal stem cells (MSCs) are multipotent cells crucial for tissue repair.
• MSCs reside in the tumor microenvironment, influencing tumor progression.
• Their immunomodulatory functions, including immunosuppression via factors like IDO, PGE2, and TGF-β, are well-documented.

Purpose of the Study:

• To investigate the complex and plastic role of MSCs within the tumor microenvironment.
• To understand how MSCs interact with other cells, such as tumor-infiltrating lymphocytes (TILs).
• To explore the implications of MSC plasticity for cancer immunotherapy.

Main Methods:

• Analysis of MSC behavior in the tumor microenvironment.
• Investigation of MSC phenotype changes induced by tumor-infiltrating lymphocytes (TILs) and their cytokines.
• Examination of cytokine signaling pathways, including IFN-γ, TNF-α, and IL-1α.

Main Results:

• MSCs exhibit plasticity, with their function modulated by the tumor microenvironment.
• Melanoma-activated TILs can induce pro-inflammatory, TH1-like phenotypes in MSCs.
• Co-stimulation with IFN-γ and TNF-α polarizes MSCs towards a TH1-like phenotype, maintaining immunosuppressive factor expression.

Conclusions:

• The role of MSCs in cancer is multifaceted and context-dependent.
• Understanding MSC plasticity is critical for developing effective cancer immunotherapies.
• Further research is needed to fully elucidate MSC functions in the tumor microenvironment and optimize therapeutic strategies.